http://vital.seals.ac.za:8080/vital/access/manager/Index en-us 5 http://vital.seals.ac.za:8080/vital/access/manager/Repository/vital:43929 Tue 14 May 2024 11:49:17 SAST ]]> http://vital.seals.ac.za:8080/vital/access/manager/Repository/vital:43991 Tue 14 May 2024 11:13:22 SAST ]]> http://vital.seals.ac.za:8080/vital/access/manager/Repository/vital:43939 Tue 14 May 2024 11:12:53 SAST ]]> http://vital.seals.ac.za:8080/vital/access/manager/Repository/vital:44271 80% NVP was released from the tablets over the test period. The NVP release rate increased with an increase in the mesh pore size; however, the extent of release was not affected by this parameter. Dissolution test samples were analyzed using HPLC, and dissolution methods were validated for NVP stability in the dissolution medium, specificity, linearity and range, repeatability, intermediate precision, and accuracy as defined by ICH. The dissolution method used for testing NVP tablets can be regarded as an appropriate tool for the evaluation of sustained-release (SR) NVP formulations and the impact of formulation composition and product quality attributes on drug release.]]> Tue 14 May 2024 11:01:21 SAST ]]>